Skip to content

Drug interactions

Alogliptin-metformin + Glibenclamide

Severity: Moderate

Alogliptin-metformin and Glibenclamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Combining a DPP-4 inhibitor with a sulfonylurea raises the risk of hypoglycemia. Glyburide has a long-acting active metabolite, so hypoglycemia may be prolonged, especially in renal impairment or older patients.

What this interaction means in plain words

Alogliptin-metformin and Glibenclamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Alogliptin-metformin belongs to Endocrine; Glibenclamide belongs to Endocrine.

Evidence level: High

Why it happens

Additive insulin-secretory effects of alogliptin (glucose-dependent) and glyburide.

What to do

Consider reducing the glyburide dose when starting alogliptin-metformin, and monitor glucose closely. Be especially careful in elderly patients or those with reduced renal function.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Alogliptin-metformin and Glibenclamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Alogliptin-metformin with Glibenclamide?

MediHelp rates the interaction as moderate. Alogliptin-metformin and Glibenclamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Combining a DPP-4 inhibitor with a sulfonylurea raises the risk of hypoglycemia. Glyburide has a long-acting active metabolite, so hypoglycemia may be prolonged, especially in renal impairment or older patients.

How serious is the interaction between Alogliptin-metformin and Glibenclamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing the glyburide dose when starting alogliptin-metformin, and monitor glucose closely. Be especially careful in elderly patients or those with reduced renal function.

What other medicines interact with Alogliptin-metformin?

MediHelp also lists interactions of Alogliptin-metformin with, for example, Clozapine, Contrast media, Diatrizoate. The full list is on the Alogliptin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in